CurrentBlue Cross Blue Shield - OklahomaPolicy CPCPLAB016

Pediatric Preventive Screening

Defines reimbursement and coding criteria for laboratory-based preventive screening tests for individuals from newborn through age 18 (excluding newborn genetic disorder screening) for BCBS Oklahoma products; applies to providers submitting claims to BCBSOK.

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyPediatric Preventive Screening

Policy CodePolicy CPCPLAB016

Change TypeRevised & clarified reimbursement informationscreenings moved to other policies

Effective DateNov 1, 2023

Next Review DateN/A

Key ActionVerify individual member plan documents for product-specific coverage and submit accurate documentation to support reimbursement.

SourceLink

POLICY UPDATE CHANGES

Reimbursement information revised for clarity and certain screenings moved to other policies (dyslipidemia for ages 17-21, STI screening, Hepatitis B annual screening).

Document updated with literature review and reimbursement information clarified.

newborn–18population covered

8+screening categories

1.0policy version

7/17/2023last committee approval

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Pediatric Preventive Laboratory Screening

Reimbursable screening categories

Screening tests may be reimbursable when the following conditions apply (per itemized categories):

Newborn screening panel may be reimbursable when it follows all applicable federal and state law recommendations.

[[chunk 3]]

Newborn hyperbilirubinemia screening: Screening for hyperbilirubinemia in all newborns may be reimbursable.

[[chunk 3]]

Newborn congenital hypothyroidism: Screening for congenital hypothyroidism in all newborns utilizing serum thyroxine (T4) and/or thyroid-stimulating hormone (TSH) may be reimbursable.

[[chunk 3]]

Newborn sickle cell disease: Screening for sickle cell disease in all newborns may be reimbursable.

[[chunk 3]]

Blood lead screening may be reimbursable for all individuals ages 12 months to 2 years, and for individuals ages 6 months to 6 years who are at increased risk for lead exposure.ages 12 months-2 years; ages 6 months-6 years if increased risk

[[chunk 3],[chunk 14]]

Anemia screening: Screening for anemia with hemoglobin or hematocrit may be reimbursable for all individuals at 12 months of age, and for individuals 4 months and older if at risk for iron deficiency.12 months routine; >=4 months if risk

[[chunk 3]]

Tuberculosis screening: For individuals 1 month of age or older who are at increased risk of contracting tuberculosis, TB screening may be reimbursable.>=1 month if increased risk

[[chunk 3]]

Dyslipidemia screening: Screening for dyslipidemia with fasting lipid profile or non-fasting non-HDL-C may be reimbursable annually for children and adolescents at increased risk due to personal or family history, and once during the age period for individuals 9-11 years (dyslipidemia screening for ages 17-21 moved to CPCPLAB020).once during age 9-11; annual if increased risk

[[chunk 3],[chunk 14]]

This policy excludes newborn genetic disorder screening from its scope; those screenings are addressed separately and are not reimbursable under this document. Additionally, specific screening types have been operationally moved to other CPCP policies: dyslipidemia screening for individuals ages 17–21 has been moved to CPCPLAB020 (Cardiovascular Disease Risk Assessment), screening for chlamydia, gonorrhea, and syphilis in sexually active or at‑risk adolescents has been moved to CPCPLAB051 (Diagnostic Testing of Common Sexually Transmitted Infections), and annual Hepatitis B screening has been moved to CPPLAB015 (Hepatitis Testing).

Inclusion of a procedure code on the policy’s coding list does not by itself guarantee that the service is a covered benefit or that the code will be reimbursed. Providers must verify member eligibility and plan‑specific coverage rules, as claim adjudication is subject to product terms, code edits, and any applicable prior authorization or billing requirements.

Procedure Codes and Related Coding Details

Listed procedure codesmixed

80061
82247
82248
82465
83020
83021
83655
83718
84439
84443

1–10 of 21

1/3

Listed procedure codes (duplicate/extra slots omitted)mixed

No codes listed

Dyslipidemia BMI percentile — overweight and obesity percentile thresholds

Overweight (BMI percentile)BMI ≥ 85th percentile and < 95th percentile

Obesity (BMI percentile)BMI ≥ 95th percentile

Source guidanceDefined per AAP dyslipidemia risk factors (Daniels et al., 2008)

Provider Responsibilities, Claims, and Documentation

Note

Coverage Varies by Product

Coverage and billing rules in this policy may vary by Blue Cross Blue Shield of Oklahoma product. Providers must review the member’s specific plan documents (Certificates of Benefits, benefit booklets, Summary Plan Descriptions, and other coverage documents) to determine eligible coverage and any product-specific requirements. If a conflict exists between this Clinical Payment and Coding Policy and a plan document, the plan document governs; if a conflict exists with a provider contract, the provider contract governs.

Not all requirements in this policy apply to every product.
Plan documents include Certificates of Health Care Benefits, benefit booklets, Summary Plan Descriptions, and other coverage documents.

Documentation Required

Documentation Requirements

Providers are responsible for submitting accurate and complete documentation to support services billed. Claims must use valid HIPAA-approved code sets and follow industry-standard coding guidelines (e.g., UB, AMA CPT, CPT Assistant, HCPCS, ICD-10-CM/PCS, NDC, DRG, CMS NCCI).

Background and Scope

This policy defines reimbursement and coding criteria for laboratory‑based preventive screening tests performed on individuals from newborn through age 18. It summarizes the categories of screenings that may be reimbursable — including the newborn screening panel (excluding genetic disorder screening), newborn hyperbilirubinemia, congenital hypothyroidism, sickle cell disease, blood lead screening, anemia screening, tuberculosis screening for those at increased risk, and dyslipidemia screening — and references age‑based thresholds and risk‑based indications for each category.

Definitions and Risk Factor Lists

Adolescent definition — WHO age range 10–19

Adolescent (age range)Any person between the age of 10 and 19 years (WHO, 2021)

Policy population scopePolicy refers to individuals newborn through age 18 for reimbursement criteria

Reference yearWHO definition cited (2021)

Lead exposure risk factors — housing, socioeconomic, recent immigration/adoption, etc.

Housing ageLiving or spending time in a house or building built before 1978

SocioeconomicGrowing up in a low‑income household

Recent immigration/adoption

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyPediatric Preventive Screening

Policy CodePolicy CPCPLAB016

Change TypeRevised & clarified reimbursement informationscreenings moved to other policies

Effective DateNov 1, 2023

Next Review DateN/A

Key ActionVerify individual member plan documents for product-specific coverage and submit accurate documentation to support reimbursement.

SourceLink

On This Page

Submit claims using valid code combinations from HIPAA-approved code sets.

Follow applicable coding guidelines and CMS edit protocols.

Denial Risk

Claim Review and Denial Risk

Claims are subject to code edit protocols and clinical review. Claims may be denied, adjusted, or returned for additional information if coding is inaccurate, unsupported by documentation, or inconsistent with benefit coverage, provider contract language, medical policies, or coding software logic. Upon request, providers should promptly submit any additional documentation to support the claim.

Claims subject to code edits and claim review processes.
Denials may occur if documentation is inaccurate or unsupported.

Prior Authorization

Provider Alert

Provider alert: BCBSOK may exercise reasonable discretion in interpreting and applying this policy to services delivered in specific cases. Providers should verify member eligibility, benefits, and any prior authorization requirements before rendering services.

If a conflict arises between this policy and plan documents or provider contracts, the governing document prevails.
Verify eligibility, benefits, and prior authorization requirements prior to services.

Being a recent immigrant, refugee, or recently adopted from less developed countries

Household exposureLiving or spending time with a person who works with lead or has hobbies that expose them to lead

Iron deficiency risk factors — prematurity/low birth weight, breastfeeding without supplementation, etc.

Prematurity / low birth weightHistory of prematurity or low birth weight

Breastfeeding without supplementationExclusive breastfeeding beyond 4 months of age without supplemental iron

Dietary intakeWeaning to whole milk or complementary foods that do not include iron‑fortified cereals or foods naturally rich in iron

Feeding/growthFeeding problems, poor growth, and inadequate nutrition

Lead exposureExposure to lead is a risk factor for iron deficiency

TB risk factors — close contact, suggestive radiographic/clinical findings, HIV risk, foreign birth, etc.

Close contactClose contact with a person with or suspected to have infectious tuberculosis

Radiographic/clinicalRadiographic or clinical findings suggestive of TB

HIV and immunosuppressionHIV infection or considered at risk for HIV infection; having a depressed immune system

Foreign birth / migrationBeing of foreign birth (especially from high‑TB areas), refugee or immigrant, or significant travel to endemic countries

Dyslipidemia risk factors — family history, overweight/obesity, hypertension, smoking, diabetes, etc.

Family historyFamily members with CVD or dyslipidemia at young ages (≤55 years for men; ≤65 years for women)

Overweight / obesityOverweight (BMI ≥ 85th and <95th percentile) or obesity (BMI ≥ 95th percentile)

HypertensionHypertension defined as blood pressure ≥ 95th percentile

Tobacco useCigarette smoking

DiabetesDiabetes mellitus